Hernando Knobel - Infectious Diseases

Author Information

Hernando Knobel is a distinguished researcher in the field of Infectious Diseases, currently affiliated with the Department of Infectious Diseases at Hospital del Mar in Barcelona, Spain. Dr. Knobel's work primarily focuses on HIV research, antiretroviral therapy, and the clinical impact of infectious diseases such as COVID-19 and influenza. His contributions have significantly advanced understanding in these areas, particularly in the context of treatment interventions and patient management.

Research Contributions

Dr. Knobel has made substantial contributions to the field of Infectious Diseases, with a particular emphasis on HIV and its associated complications. His recent research includes comparative studies on antiretroviral therapies for HIV, clinical analyses of COVID-19 versus influenza in hospitalized patients, and investigations into the factors affecting neurocognitive impairment in older adults living with HIV. He has also explored the dynamics of renal function in patients under antiretroviral treatment and the delayed diagnosis of tuberculosis in HIV-positive individuals. Dr. Knobel's work is characterized by its clinical relevance and its focus on improving patient outcomes.

Aliases

Throughout his academic and research career, Hernando Knobel has been referenced under several aliases, including H Knobel, H. H. Knobel, and H. Knobel. These variations are likely due to different publication conventions and indexing by various databases.

Publication and Citation Metrics

Metric	Value
Citation Count	6753
H-index	43
Paper Count	210

Publications:

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

DOI: 10.1093/ofid/ofab595

Year: 2022

Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption.

DOI: 10.1093/cid/ciac314

Year: 2022

Factors associated to neurocognitive impairment in older adults living with HIV

DOI: 10.1186/s40001-022-00639-6

Year: 2022

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

DOI: 10.2147/IDR.S294299

Year: 2021

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

DOI: 10.1016/S2352-3018(21)00240-X

Year: 2021

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

DOI: 10.2139/ssrn.3854773

Year: 2021

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

DOI: 10.1093/jac/dkaa547

Year: 2021

HIV Infection is Associated with Upregulated Circulating Levels of miR-21-5p

DOI: 10.2139/ssrn.3854603

Year: 2021

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

DOI: 10.1186/s12879-021-06745-w

Year: 2021

Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment

DOI: 10.37201/req/055.2021

Year: 2021

How can public health responses be improved?

What Are Sexually Transmitted Infections (STIs)?

How Does WHO Address Infectious Diseases?

How Can Chlamydia Be Prevented?

What is One Health?

How to Interpret Stool Sample Results?

How is Strep Throat Diagnosed?

Why is Insect Repellent Important in Preventing Infectious Diseases?

What Can Be Done to Mitigate These Effects?

How should Dexamethasone be administered?

Partnered Content Networks

Relevant Topics